CHIME syndrome

Lore & Background

CHIME syndrome was first described in 1983. The acronym CHIME is based on its main symptoms: colobomas, heart defects, ichthyosiform dermatosis, intellectual disability, and either ear defects or epilepsy. Associated symptoms include colobomas of the eyes, heart defects, ichthyosiform dermatosis, intellectual disability, and ear abnormalities. Further symptoms that may be suggested include characteristic facies, hearing loss, and cleft palate.

Reader's Guide

CHIME syndrome is a rare congenital ichthyosis with only a few cases studied and published. Its significance lies in its autosomal recessive inheritance pattern, meaning two copies of the defective gene, one from each parent, are required to inherit the disorder. Treatment with isotretinoin may induce substantial resolution of skin lesions, but the risk of secondary infection remains. The syndrome's legacy is as a distinct neuroectodermal disorder, with ongoing study needed due to its rarity.

Did You Know?

• The syndrome is also known as Zunich–Kaye syndrome or Zunich neuroectodermal syndrome.
• It has an autosomal recessive inheritance pattern, requiring two copies of the defective gene.
• Treatment with isotretinoin may substantially resolve skin lesions, but secondary infection risk remains.

Discovery and the CHIME Acronym

CHIME syndrome entered the medical literature in 1983, when a cluster of striking developmental abnormalities was first formally described and linked into a single diagnostic entity. The condition is a rare congenital ichthyosis, and its very name is a clinical shorthand: the letters C, H, I, M, and E stand for the five hallmark features that tend to appear together—colobomas, heart defects, ichthyosiform dermatosis, intellectual disability, and either ear anomalies or epilepsy. Because the syndrome was initially recognized through the work of researchers Zunich and Kaye, it also carries the alternative labels Zunich–Kaye syndrome and Zunich neuroectodermal syndrome, names that honor the clinicians who first pieced the pattern together. Despite more than four decades passing since that initial description, the condition remains extraordinarily uncommon; only a handful of cases have been studied and published in the peer-reviewed literature, which means that even experienced dermatologists and geneticists may encounter it only once in a career. This scarcity of documented cases has made each new report a valuable addition to a still-very-small body of knowledge.

The Spectrum of Clinical Findings

A child born with CHIME syndrome presents with a constellation of abnormalities that span multiple organ systems, making the clinical picture both complex and distinctive. The five features encoded in the acronym—ocular colobomas, structural heart defects, a thickened scaly skin condition known as ichthyosiform dermatosis, intellectual disability, and either malformations of the ear or a tendency toward seizures—form the core diagnostic set. Beyond that core, affected individuals may also display a recognizable facial appearance, often described as characteristic facies, alongside hearing loss and a cleft palate. The ichthyosiform dermatosis, a congenital form of severe skin scaling, is particularly prominent and was in fact the feature that drew early attention to the condition, since it is the most visible and immediately apparent abnormality at birth. The neurologic and ophthalmologic involvement, combined with the cardiac and dermatologic findings, underscores that the syndrome is a multi-system developmental disorder rather than a single-organ problem. Because so few cases have been documented, the full range of possible presentations is still being delineated, and each newly reported patient can reveal additional signs that were not previously catalogued.

Genetic Inheritance Pattern

CHIME syndrome follows an autosomal recessive inheritance pattern, a detail that carries important implications for families and for genetic counseling. In practical terms, this means the defective gene responsible for the condition sits on one of the non-sex chromosomes—an autosome—rather than on the X or Y chromosome. For a child to be affected, they must inherit two copies of the faulty gene, one contributed by each parent. Crucially, each parent typically carries only a single copy of the defective variant and therefore does not display the syndrome themselves; they are asymptomatic carriers. This recessive mechanism explains why the condition can appear to arise seemingly without warning in a family with no prior history of ichthyosis, heart defects, or the other hallmark features. Both parents must be carriers, and the probability of any given pregnancy producing an affected child is one in four, though the extreme rarity of the underlying mutation means that two carriers meeting and having children is itself an exceedingly unlikely event. The autosomal recessive classification was confirmed through family studies reported in the late 1980s, solidifying the genetic framework within which the syndrome is understood.

Treatment and the Challenge of Rarity

Managing CHIME syndrome is complicated by the fact that no single therapy addresses all of its multi-system features, and the condition's extreme rarity means that treatment protocols are largely drawn from case-by-case clinical judgment rather than large-scale trials. For the ichthyosiform dermatosis—the thickened, scaly skin that is often the most visually striking manifestation—systemic isotretinoin has been used and may produce substantial clearing of the skin lesions. However, even when the skin improves markedly, the risk of secondary infection persists, requiring ongoing monitoring and supportive care. There is no comparable single intervention for the cardiac defects, ocular colobomas, intellectual disability, or the ear abnormalities and epilepsy that round out the clinical picture; those features demand their own specialized management by cardiologists, ophthalmologists, neurologists, and other specialists. Long-term follow-up of the small number of published cases has been essential to understanding the natural history of the syndrome, and individual reports have even documented serious comorbidities such as acute lymphoblastic leukemia in a child with the condition. The overall picture is one of multidisciplinary, lifelong care shaped by the unique needs of each affected individual.

Gallery